These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25775144)

  • 1. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.
    Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H
    Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.
    Shimojima Y; Ishii W; Matsuda M; Tazawa K; Ikeda S
    BMC Musculoskelet Disord; 2012 Nov; 13():228. PubMed ID: 23173570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
    Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
    Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
    Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis.
    Ueno KI; Shimojima Y; Kishida D; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2016 Dec; 19(12):1322-1330. PubMed ID: 27457756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.
    Matsubara S; Kondo K; Sugaya K; Miyamoto K
    Clin Rheumatol; 2012 Oct; 31(10):1493-8. PubMed ID: 22886003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
    Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N
    Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
    Kuwana M; Wakasugi N; Furuya T; Uno S; Suda T
    J Rheumatol; 2022 Jul; 49(7):707-718. PubMed ID: 35428708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early treatment in polymyositis and dermatomyositis.
    Naji P; Shahram F; Nadji A; Davatchi F
    Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
    Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
    Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
    Shimojima Y; Gono T; Yamamoto K; Hoshi K; Matsuda M; Yoshida K; Ikeda S
    Clin Rheumatol; 2004 Jun; 23(3):262-5. PubMed ID: 15168159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
    Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
    Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
    Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
    Sharma N; Putman MS; Vij R; Strek ME; Dua A
    J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
    Fujisawa T; Hozumi H; Kamiya Y; Kaida Y; Akamatsu T; Kusagaya H; Satake Y; Mori K; Mikamo M; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respirology; 2021 Apr; 26(4):370-377. PubMed ID: 33179395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.